Literature DB >> 8775947

Role of echocardiography in primary care medicine. Controversies in hypertension, atrial fibrillation, stroke, and endocarditis.

T M Amidon1, T M Chou, L L Kee, E Foster.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8775947      PMCID： PMC1303430     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  56 in total

1.  Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography.

Authors:  R A Grimm; W J Stewart; J D Maloney; G I Cohen; G L Pearce; E E Salcedo; A L Klein
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

Review 2.  Systemic arterial emboli and cardiac masses. Assessment with transesophageal echocardiography.

Authors:  F A Dressler; A J Labovitz
Journal:  Cardiol Clin       Date:  1993-08       Impact factor: 2.213

3.  Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography.

Authors:  C Movsowitz; H D Movsowitz; L E Jacobs; C B Meyerowitz; L A Podolsky; M N Kotler
Journal:  J Am Soc Echocardiogr       Date:  1993 Mar-Apr       Impact factor: 5.251

4.  Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients.

Authors:  M Di Tullio; R L Sacco; N Venketasubramanian; D Sherman; J P Mohr; S Homma
Journal:  Stroke       Date:  1993-07       Impact factor: 7.914

5.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.

Authors:  J D Neaton; R H Grimm; R J Prineas; J Stamler; G A Grandits; P J Elmer; J A Cutler; J M Flack; J A Schoenberger; R McDonald
Journal:  JAMA       Date:  1993-08-11       Impact factor: 56.272

6.  Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi.

Authors:  W J Manning; D I Silverman; S P Gordon; H M Krumholz; P S Douglas
Journal:  N Engl J Med       Date:  1993-03-18       Impact factor: 91.245

7.  Left ventricular hypertrophy as a risk factor in arterial hypertension.

Authors:  W B Kannel
Journal:  Eur Heart J       Date:  1992-09       Impact factor: 29.983

8.  Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis.

Authors:  R A Sochowski; K L Chan
Journal:  J Am Coll Cardiol       Date:  1993-01       Impact factor: 24.094

9.  Left ventricular hypertrophy and mortality--results from the Framingham Study.

Authors:  W B Kannel; J Cobb
Journal:  Cardiology       Date:  1992       Impact factor: 1.869

10.  Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman; B M Massie; E D Freis; M S Kochar; R J Hamburger; C Fye; R Lakshman; J Gottdiener
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.